QuinnE.CoxF.: Bacterial Endocarditis: Based Upon Experience with 203 Patients, in Antimicrobial Therapy, (KaganB., editor) page 260, W. B. Saunders Co., Philadelphia, 1970.
8.
GoodmanL.GilmanA. (editors): The Pharmacological Basis of Therapeutics, 4th edition, page 1222, The Macmillan Co., N. Y., 1970.
9.
KuninC.: Clinical Pharmacology of the New Penicillins I. The Importance of Serum Protein Binding in Determining Antimicrobial Activity and Concentration in Serum, Clin. Pharmacol. Therap.7: 166 (Mar.-Apr.) 1966.
10.
KislackJ.: Cloxacillin; Activity in Vitro, and Absorption and Urinary Excretion in Normal Young Men, Am. J. Med. Sci.249: 636 (June) 1965.
11.
GoodmanL.GilmanA. (editors): The Pharmacological Basis of Therapeutics, 4th edition, page 1293, The Macmillan Company, N. Y., 1970.
12.
MoserR. (editor): Diseases of Medical Progress: A Study of Iatrogenic Disease, 3rd edition, page 23 and 575, Charles C Thomas, Springfield, Ill., 1969.
13.
KirbyW.: Vancomycin Therapy of Staphylococcal Infections Second International Symposium on Chemotherapy, 1: 84, 1963, as cited in Am. J. Med.38: 409 (Mar.) 1965.
14.
SchreinerG.MaherJ.: Toxic Nephropathy, Am. J. Med.38: 409 (Mar.) 1965.